Cutaneous manifestations of graft-versus-host disease: role of the dermatologist (Q38961868)

8 September 2017

1 reference

title

Cutaneous manifestations of graft-versus-host disease: role of the dermatologist (English)

1 reference

8 September 2017

2

Julia S Lehman

1 reference

8 September 2017

Sima Kavand

1

1 reference

8 September 2017

Shahrukh Hashmi

series ordinal

3

1 reference

8 September 2017

Lawrence E Gibson

series ordinal

4

1 reference

8 September 2017

Rokea A El-Azhary

series ordinal

5

1 reference

8 September 2017

publication date

23 September 2016

1 reference

International Journal of Dermatology

8 September 2017

published in

1 reference

8 September 2017

volume

56

1 reference

8 September 2017

issue

2

1 reference

8 September 2017

page(s)

131-140

1 reference

Analysis of risk factors for acute cutaneous graft-versus-host disease after allogeneic stem cell transplantation

8 September 2017

cites work

1 reference

Cutaneous graft-versus-host disease: a guide for the dermatologist

21 January 2018

1 reference

Current status of reduced-intensity-conditioning allogeneic stem cell transplantation for acute myeloid leukemia

21 January 2018

1 reference

Fatal graft-versus-host disease after unrelated cadaveric liver transplantation due to donor/recipient human leucocyte antigen matching.

21 January 2018

1 reference

Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria

21 January 2018

1 reference

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report

21 January 2018

1 reference

The biology of graft-versus-host disease: experimental systems instructing clinical practice

21 January 2018

1 reference

Current issues in chronic graft-versus-host disease

21 January 2018

1 reference

Transplantation's greatest challenges: advances in chronic graft-versus-host disease

21 January 2018

1 reference

Diverse T-cell responses characterize the different manifestations of cutaneous graft-versus-host disease

21 January 2018

1 reference

Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival.

21 January 2018

1 reference

A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study

21 January 2018

1 reference

Elafin is a biomarker of graft-versus-host disease of the skin

21 January 2018

1 reference

First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation

21 January 2018

1 reference

Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management.

21 January 2018

1 reference

Acute cutaneous graft-versus-host disease resembling type II (atypical adult) pityriasis rubra pilaris

21 January 2018

1 reference

Atypical manifestations of graft-versus-host disease.

21 January 2018

1 reference

Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD.

21 January 2018

1 reference

Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease

21 January 2018

1 reference

Lichen sclerosus and eosinophilic fasciitis as manifestations of chronic graft-versus-host disease: expanding the sclerodermoid spectrum.

21 January 2018

1 reference

Diagnosis and manifestations of chronic graft-versus-host disease

21 January 2018

1 reference

Erythema multiforme-like presentation of chronic graft versus host disease

21 January 2018

1 reference

Value of skin biopsies in assessing prognosis and progression of acute graft-versus-host disease.

21 January 2018

1 reference

Acute cutaneous graft-vs.-host disease compared to drug hypersensitivity reaction with vacuolar interface changes: a blinded study of microscopic and immunohistochemical features

21 January 2018

1 reference

Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report.

21 January 2018

1 reference

T-cell and natural killer cell therapies for hematologic malignancies after hematopoietic stem cell transplantation: enhancing the graft-versus-leukemia effect

21 January 2018

1 reference

Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice.

21 January 2018

1 reference

Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes

21 January 2018

1 reference

Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD.

21 January 2018

1 reference

Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells

21 January 2018

1 reference

Altered regulatory T cell homeostasis in patients with CD4 lymphopenia following allogeneic hematopoietic stem cell transplantation.

21 January 2018

1 reference

Psoralen plus ultraviolet-A-bath photochemotherapy as an adjunct treatment modality in cutaneous chronic graft versus host disease.

21 January 2018

1 reference

Narrowband ultraviolet B phototherapy for the treatment of steroid-refractory and steroid-dependent acute graft-versus-host disease of the skin

21 January 2018

1 reference

PUVA therapy decreases HLA-DR CDIa Langerhans cells and epidermal cell antigen-presenting capacity in human skin, but flow cytometrically-sorted residual HLA-DR CDIa Langerhans cells exhibit normal alloantigen-presenting function.

21 January 2018

1 reference

Dermatologic treatment of cutaneous graft versus host disease.

21 January 2018

1 reference

Cutaneous graft-versus-host disease: rationales and treatment options

21 January 2018

1 reference

Rituximab for steroid-refractory chronic graft-versus-host disease

21 January 2018

1 reference

Tumor necrosis factor-alpha blockade for the treatment of acute GVHD.

21 January 2018

1 reference

Anti-IL-12/23 p40 antibody attenuates experimental chronic graft-versus-host disease via suppression of IFN-γ/IL-17-producing cells

21 January 2018

1 reference

Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease

21 January 2018

1 reference

Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study

21 January 2018

1 reference

Medium dose long-wavelength ultraviolet A (UVA1) phototherapy for the treatment of acute and chronic graft-versus-host disease of the skin

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/IJD.13381

1 reference

8 September 2017

1 reference